Home Pilots Seer Medical receives FDA 510(k) for its at-home epilepsy diagnosis aide Pilots Seer Medical receives FDA 510(k) for its at-home epilepsy diagnosis aide By - September 26, 2022 31 0 Facebook Twitter Pinterest WhatsApp The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES AIRS Medical scores $20M for global expansion and more briefs Pilots - July 22, 2024 0 Latest diabetes management app in Singapore connects patients, doctors, health coaches in one platform Pilots - January 12, 2022 0 Flipkart Health+ mobile health app goes live Pilots - April 7, 2022 0 Healthcare spatial data company Kontakt.io raises $47.5M from Goldman Sachs Pilots - April 16, 2024 0 GSK pays $70M to increase its access to Tempus patient data library Pilots - October 19, 2022 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3